| Emily W Shelley, DO | |
|
8433 Harcourt Rd Ste 310, Indianapolis, IN 46260-2198 | |
| (173) 338-9393 | |
| Not Available |
| Full Name | Emily W Shelley |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Location | 8433 Harcourt Rd Ste 310, Indianapolis, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467834127 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 02005655A (Indiana) | Primary |
| Entity Name | Dermatology Associates Of Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861613564 PECOS PAC ID: 6507931649 Enrollment ID: O20080825000155 |
News Archive
The National Viral Hepatitis Roundtable (NVHR) is hosting a briefing, "The Experts' Perspective: Gaps and Strategies in the Hepatitis Crisis." "Leading hepatitis physicians, one of whom is a Congressman, will be on the hill today to educate Congress on the importance of developing a strategy to reduce the significant morbidity and mortality from end-stage liver disease and liver cancer caused by chronic hepatitis B and chronic hepatitis C in the United States," said Martha Saly, Director of NVHR.
VaxOnco, a leading oncology biopharmaceutical company, today announced that following FDA IND approval, it will sponsor a Phase I folate receptor alpha-targeted therapeutic vaccine clinical trial in disease-free patients, previously diagnosed with either breast or ovarian cancer at Mayo Clinic.
BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has signed a definitive agreement to merge Utah-based Glycosan BioSystems, Inc. (Glycosan) with BioTime's wholly-owned subsidiary, OrthoCyte Corporation. The acquisition is expected to close by March 18, 2011.
Low birthweight is the most common negative outcome of smoking during pregnancy, but foetuses exposed to maternal smoking are also at risk of premature birth and the associated problem of brain damage, as well as congenital abnormalities such as cleft lip.
Consumer Watchdog has called on Gov. Arnold Schwarzenegger to withdraw weak pseudo-reforms of the health insurance industry that would bar strong regulation of health insurers. Schwarzenegger sent his proposals this month to lawmakers who are seeking stronger state regulation modeled on the successful market reforms of auto and homeowner insurance under Proposition 103, demanding that they substitute his legislation for their bills.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily W Shelley, DO 8433 Harcourt Rd Ste 310, Indianapolis, IN 46260-2198 Ph: (317) 338-9393 | Emily W Shelley, DO 8433 Harcourt Rd Ste 310, Indianapolis, IN 46260-2198 Ph: (173) 338-9393 |
News Archive
The National Viral Hepatitis Roundtable (NVHR) is hosting a briefing, "The Experts' Perspective: Gaps and Strategies in the Hepatitis Crisis." "Leading hepatitis physicians, one of whom is a Congressman, will be on the hill today to educate Congress on the importance of developing a strategy to reduce the significant morbidity and mortality from end-stage liver disease and liver cancer caused by chronic hepatitis B and chronic hepatitis C in the United States," said Martha Saly, Director of NVHR.
VaxOnco, a leading oncology biopharmaceutical company, today announced that following FDA IND approval, it will sponsor a Phase I folate receptor alpha-targeted therapeutic vaccine clinical trial in disease-free patients, previously diagnosed with either breast or ovarian cancer at Mayo Clinic.
BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has signed a definitive agreement to merge Utah-based Glycosan BioSystems, Inc. (Glycosan) with BioTime's wholly-owned subsidiary, OrthoCyte Corporation. The acquisition is expected to close by March 18, 2011.
Low birthweight is the most common negative outcome of smoking during pregnancy, but foetuses exposed to maternal smoking are also at risk of premature birth and the associated problem of brain damage, as well as congenital abnormalities such as cleft lip.
Consumer Watchdog has called on Gov. Arnold Schwarzenegger to withdraw weak pseudo-reforms of the health insurance industry that would bar strong regulation of health insurers. Schwarzenegger sent his proposals this month to lawmakers who are seeking stronger state regulation modeled on the successful market reforms of auto and homeowner insurance under Proposition 103, demanding that they substitute his legislation for their bills.
› Verified 3 days ago
Kathryn Shrift, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7910 N Shadeland Ave, Indianapolis, IN 46250 Phone: 317-516-5000 Fax: 317-516-5146 | |
Dr. Scott A Fretzin, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7910 N Shadeland Ave, Indianapolis, IN 46250 Phone: 317-516-5000 Fax: 317-516-5146 | |
Matthew Turner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 545 Barnhill Dr, Eh 139, Indianapolis, IN 46202 Phone: 317-274-7705 | |
Dr. Anubhav Narain Mathur, MD/PHD Dermatology Medicare: Medicare Enrolled Practice Location: 1001 W 10th St, Opw M200, Indianapolis, IN 46202 Phone: 317-656-4260 | |
Vindhya Lakshmi Veerula, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1001 W 10th St # M200, Indianapolis, IN 46202 Phone: 317-656-4260 | |
Daniel Hekman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8325 E Southport Rd Ste 100, Indianapolis, IN 46259 Phone: 317-862-6609 Fax: 317-862-4617 | |
Christy Lynn Nebesio, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7910 N Shadeland Ave, Indianapolis, IN 46250 Phone: 317-516-5000 Fax: 317-516-5146 |